Document Detail

Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: Report of a case and review of the literature.
MedLine Citation:
PMID:  21635826     Owner:  NLM     Status:  In-Data-Review    
Dermatologic manifestations from therapy with imatinib are well known and frequently include hypopigmentation, and less commonly, hyperpigmentation. There have been few reports of oral hyperpigmentation. We present a case of palatal melanosis related to imatinib therapy for chronic myelogenous leukemia. This case is reported to add to the sparse literature concerning mucosal reactions related to this medication.
Michelle Wong; Shachar Sade; Melanie Gilbert; Hagen B E Klieb
Related Documents :
20688296 - Plesiomonas shigelloides sepsis and meningoencephalitis in a surviving neonate.
1254706 - Meningitis due to aeromonas hydrophila.
14620646 - Eosinophilic meningitis: a case series report and review of the literature.
3826896 - A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial ...
16636626 - Atypical traumatic craniocervical junction focal spinal subdural hematoma.
22445006 - Quality assurance peer review chart rounds in 2011: a survey of academic institutions i...
Publication Detail:
Type:  Journal Article     Date:  2011-05-15
Journal Detail:
Title:  Dermatology online journal     Volume:  17     ISSN:  1087-2108     ISO Abbreviation:  Dermatol. Online J.     Publication Date:  2011  
Date Detail:
Created Date:  2011-06-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610776     Medline TA:  Dermatol Online J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4     Citation Subset:  IM    
University of Toronto, Sunnybrook Health Sciences Center, Department of Dentistry.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Generalized linear porokeratosis: A rare entity with excellent response to acitretin.
Next Document:  Cutaneous fusariosis developing in a post-irradiation site.